-
1
المؤلفون: Erik Hille, Mark Belger, Patrick L. McCollam, Theodore Spiro, Russel Burge, KA Kelton, Tim Klein, Daniel R Murphy
المصدر: Advances in Therapy
مصطلحات موضوعية: Marginal cost, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Baricitinib, Total cost, Hospitalized patients, Cost effectiveness, Cost-Benefit Analysis, medicine.medical_treatment, Remdesivir, Hospital, Mechanical ventilation, medicine, Humans, Pharmacology (medical), health care economics and organizations, Reimbursement, Original Research, Sulfonamides, Alanine, SARS-CoV-2, business.industry, COVID-19, General Medicine, Adenosine Monophosphate, United States, COVID-19 Drug Treatment, Purines, Emergency medicine, Azetidines, Pyrazoles, Cost-effectiveness, Quality-Adjusted Life Years, business
-
2
المؤلفون: Russel Burge, Casey Choong, Patrick Mc Collam, Hamed Abedtash, KA Kelton, Robert L. Ohsfeldt
المصدر: Advances in Therapy
مصطلحات موضوعية: Intensive care unit (ICU), Adult, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), medicine.medical_treatment, Intensive care, Health care, Extracorporeal membrane oxygenation, Humans, Medicine, Pharmacology (medical), Hospital Costs, health care economics and organizations, Disease burden, Original Research, Aged, Retrospective Studies, Mechanical ventilation, Inpatients, SARS-CoV-2, business.industry, COVID-19, Retrospective cohort study, General Medicine, Length of Stay, United States, Intensive Care Units, Emergency medicine, Resource use, Female, business, Post-acute care
-
3
المؤلفون: Neera Ahuja, Tim Klein, Patrick Mc Collam, Russel Burge, Theodore Spiro, KA Kelton, Robert L. Ohsfeldt, Mark Belger
المصدر: Clinical Therapeutics
مصطلحات موضوعية: Adult, medicine.medical_specialty, Standard of care, Coronavirus disease 2019 (COVID-19), Baricitinib, Cost effectiveness, Hospitalized patients, medicine.medical_treatment, Cost-Benefit Analysis, Indirect costs, Hospital, Mechanical ventilation, medicine, Humans, Pharmacology (medical), Mortality, health care economics and organizations, Pharmacology, Sulfonamides, business.industry, SARS-CoV-2, COVID-19, Standard of Care, United States, COVID-19 Drug Treatment, Safety profile, Purines, Emergency medicine, Azetidines, Pyrazoles, Original Article, Quality-Adjusted Life Years, business
-
4
المؤلفون: Y Asukai, Robert L. Ohsfeldt, Sulabha Ramachandran, Ronald C Wielage, KA Kelton, Murray B. Urowitz
المصدر: Annals of the Rheumatic Diseases
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Immunology, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Systemic Lupus Erythematosus, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Internal medicine, medicine, Clinical endpoint, Humans, Lupus Erythematosus, Systemic, Immunology and Allergy, In patient, 030212 general & internal medicine, Propensity Score, 030203 arthritis & rheumatology, Systemic lupus erythematosus, treatment, business.industry, Standard of Care, Middle Aged, medicine.disease, Belimumab, Organ damage, Treatment Outcome, Propensity score matching, Cohort, Disease Progression, Female, business, disease activity, Immunosuppressive Agents, medicine.drug
-
5
المؤلفون: JC Gahn, E. Johannes, P. Kandaswamy, RW Klein, G. Baxter, KA Kelton
المصدر: Value in Health. 21:S297
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Cost effectiveness, Health Policy, Public Health, Environmental and Occupational Health, Medicine, business, Intensive care medicine, medicine.disease, Gout
-
6
المؤلفون: Sulabha Ramachandran, RW Klein, Y Asukai, JC Gahn, KA Kelton
المصدر: Value in Health. 20:A556
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Cost effectiveness, Health Policy, Public Health, Environmental and Occupational Health, medicine, Formulary, business, Intensive care medicine, Belimumab, medicine.drug
-
7دورية أكاديمية
المؤلفون: Ohsfeldt RL; Texas A&M University, College Station, TX, USA., Choong CK; Eli Lilly and Company, Indianapolis, IN, USA., Mc Collam PL; Eli Lilly and Company, Indianapolis, IN, USA., Abedtash H; Eli Lilly and Company, Indianapolis, IN, USA., Kelton KA; Medical Decision Modeling Inc., Indianapolis, IN, USA., Burge R; GPORWE-Bio-Medicines, Eli Lilly and Company, Indianapolis, IN, USA. rburge@lilly.com.; University of Cincinnati, Cincinnati, OH, USA. rburge@lilly.com.
المصدر: Advances in therapy [Adv Ther] 2021 Nov; Vol. 38 (11), pp. 5557-5595. Date of Electronic Publication: 2021 Oct 05.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther
مواضيع طبية MeSH: COVID-19* , Hospital Costs*, Adult ; Aged ; Female ; Humans ; Inpatients ; Intensive Care Units ; Length of Stay ; Retrospective Studies ; SARS-CoV-2 ; United States
-
8دورية أكاديمية
المؤلفون: Urowitz MB; Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada m.urowitz@utoronto.ca., Ohsfeldt RL; School of Public Health, Texas A&M University, College Station, Texas, USA.; Medical Decision Modeling Inc, Indianapolis, Indiana, USA., Wielage RC; Medical Decision Modeling Inc, Indianapolis, Indiana, USA., Kelton KA; Medical Decision Modeling Inc, Indianapolis, Indiana, USA., Asukai Y; Value Evidence & Outcomes, GSK, Brentford, UK., Ramachandran S; Value Evidence & Outcomes, GSK, Philadelphia, Pennsylvania, USA.
المصدر: Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Mar; Vol. 78 (3), pp. 372-379. Date of Electronic Publication: 2019 Jan 04.
نوع المنشور: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*therapeutic use , Immunosuppressive Agents/*therapeutic use , Lupus Erythematosus, Systemic/*drug therapy , Lupus Erythematosus, Systemic/*pathology, Adult ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Propensity Score ; Severity of Illness Index ; Standard of Care ; Treatment Outcome
-
9دورية أكاديمية
المؤلفون: Kelton KA; a Medical Decision Modeling , Indianapolis , IN , USA., Perk S; a Medical Decision Modeling , Indianapolis , IN , USA., Loveland S; b Roper St. Francis , Charleston , SC , USA., Perez-Nieves M; c Eli Lilly and Company , Indianapolis , IN , USA., Fu H; c Eli Lilly and Company , Indianapolis , IN , USA., Peng X; c Eli Lilly and Company , Indianapolis , IN , USA.
المصدر: Journal of medical economics [J Med Econ] 2017 May; Vol. 20 (5), pp. 533-540. Date of Electronic Publication: 2017 Feb 16.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE
مواضيع طبية MeSH: Diabetes Mellitus/*drug therapy , Hypoglycemic Agents/*economics , Insulin/*economics , Pharmacy Service, Hospital/*economics, Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Drug Delivery Systems ; Female ; Humans ; Hypoglycemic Agents/administration & dosage ; Insulin/administration & dosage ; Insulin Aspart/administration & dosage ; Insulin Aspart/economics ; Insulin Lispro/administration & dosage ; Insulin Lispro/economics ; Male ; Middle Aged ; Models, Econometric ; Retrospective Studies ; Young Adult